Answers are grounded in this paper and cite their sources.
PwT2D valued insulin efficacy and reducing treatment-related adverse events, with heterogeneity in the relative importance of administration frequency. All else being equal, respondents preferred weekly over daily basal insulin. These findings provide insights into the preferences of PwT2D considering weekly long-acting insulin.
No takes yet. Share an insight, caveat, or question.
GELSEY et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: